Evidence map›Paper›PMID 38543567›Full record

ArticleMicroorganisms2024

A Study on the Application of Recombinant Factor C (rFC) Assay Using Biopharmaceuticals.

Da Hee Kang, Song Yeol Yun, SoYoung Eum, Kyung Eun Yoon, Seung-Rel Ryu, Chulhyun Lee, Hye-Ryeon Heo, Kwang Moon Lee

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Da Hee KangBiologics Research Division, Pharmaceutical and Medical Device Research Department, National Institute of Food and Drug Safety Evaluation, Cheongju 28159, Republic of Korea.ORCID 0009-0002-0932-7467
Song Yeol YunBiologics Research Division, Pharmaceutical and Medical Device Research Department, National Institute of Food and Drug Safety Evaluation, Cheongju 28159, Republic of Korea.ORCID 0009-0005-7039-701X
SoYoung EumBiologics Research Division, Pharmaceutical and Medical Device Research Department, National Institute of Food and Drug Safety Evaluation, Cheongju 28159, Republic of Korea.
Kyung Eun YoonBiologics Research Division, Pharmaceutical and Medical Device Research Department, National Institute of Food and Drug Safety Evaluation, Cheongju 28159, Republic of Korea.
Seung-Rel RyuBiologics Research Division, Pharmaceutical and Medical Device Research Department, National Institute of Food and Drug Safety Evaluation, Cheongju 28159, Republic of Korea.
Chulhyun LeeBiologics Research Division, Pharmaceutical and Medical Device Research Department, National Institute of Food and Drug Safety Evaluation, Cheongju 28159, Republic of Korea.
Hye-Ryeon HeoBiologics Research Division, Pharmaceutical and Medical Device Research Department, National Institute of Food and Drug Safety Evaluation, Cheongju 28159, Republic of Korea.
Kwang Moon LeeBiologics Research Division, Pharmaceutical and Medical Device Research Department, National Institute of Food and Drug Safety Evaluation, Cheongju 28159, Republic of Korea.
National Institute of Food and Drug Safety Evaluation · KR

Funding

National institute of Food and Drug Safety Evaluation 21171MFDS183National institute of Food and Drug Safety Evaluation 23201MFDS138
6 · The paper itself

Abstract

Gram-negative bacterial endotoxins can cause pathophysiological effects such as high fever when introduced into the bloodstream. Therefore, endotoxin testing is necessary when producing injectable pharmaceuticals. The pharmaceutical industry has widely used

Indexed as

bacterial endotoxin testingendotoxinLimulus amebocyte lysaterecombinant factor C

Identifiers

PMID38543567
PMCPMC10972375
OpenAlexW4392382094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.